| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 22.08 | 12.1% | 1.5% |
| Total Income | 23.32 | 16.0% | 5.1% |
| Expenditure | 19.99 | 3.2% | 425.2% |
| PBT | 3.33 | 53.1% | 41.2% |
| Net Profit | 1.40 | 71.4% | 68.3% |
| OPM | 14.55% | 7.58pp | 3.29pp |
| NPM | 6.00% | 11.65pp | 12.50pp |
| EPS | 1.01 | 46.0% | 46.8% |
ABM Knowledgeware Reports Q2 FY 2025-26 Financial Results with 25% Gross Profit Margin and 9% Net Profit Margin
15 Nov 2025 · 15 Nov 2025, 12:22 pm
Summary
ABM Knowledgeware, a software and services company operating in E-governance, Cybersecurity and Agritech, has announced its financial results for the quarter and half-year ended September 30, 2025. The company has achieved approximately 25% Gross Profit Margin and 9% Net Profit Margin, but the profits are lower than the corresponding quarter of last FY due to continued investment in global market development for Scanit and cyclic billing impact on InstaSafe’s quarter billing. The company has reported operational revenue of ₹22 crores for Q2 FY 2025-26 and consolidated EBITDA, PBT, and PAT of ₹4.5 crores, ₹3.3 crores, and <₹2 crores respectively.
Key Highlights
- 1
Q2 FY 2025-26 operational revenue of ₹22 crores for ABM Knowledgeware
- 2
Consolidated EBITDA, PBT, and PAT of ₹4.5 crores, ₹3.3 crores, and <₹2 crores respectively
- 3
Approximately 25% Gross Profit Margin and 9% Net Profit Margin
- 4
Continued investment in global market development for Scanit
- 5
Cyclic billing impact on InstaSafe’s quarter billing
- 6
7% year-over-year growth in Digital Governance standalone revenue
- 7
Loss in InstaSafe Technologies Private Limited due to delayed billing
- 8
New commercial pilots and orders for Scanit in Agritech
- 9
Expected order from a large agritech company in India for Scanit
- 10
Establishing India’s first Autonomous Airborne Pathogen Surveillance Network in two Districts of Maharashtra
- 11
Signing MOU with Agharkar Research Institute for teaching new fungal pathogens
Management Comments
Management of ABM Knowledgeware
ABM has been investing into Scanit Technologies Inc, Silicon Valley, USA. Scanit has a multipatented disruptive technology in the field of autonomous detection of invisible airborne fungal pathogens before onset of the disease. This technology has applications in Agriculture as well as Human Allergy. There is a global traction for this technology with commercial installations in several countries. Being a completely new technology, the adoption needs to undergo a slow cycle of commercial pilots, 3 party validations and gradual scaling. ABM will continue investing in the market development. Similarly, ABM has undertaken serious efforts to diversify from single customer category to multiple customer categories in govt sector. Out of these categories such as Digital Project Management, Financial Reforms, Online building Approval System have started yielding results. However the longer gestation cycles in these newer areas and gradual maturity of internal capabilities of ABM will result in delayed positive impact on the ABM financials. These factors will continue to show impact on lower profits in the ABM’s standlone and consolidated profitability for next 1-1.5 years.
Informational and educational content only. Not investment advice.